PDA drag panel
BUSINESS ANALYSIS DECADAL
: American Biogenetic Sciences Inc. engages in the research and development of cardiovascular and neurobiology products for commercial development. For the 3 months ended3/31/00, revenues rose from $332K to $959K. Net loss avail.to Common rose from $1.5M to $2.9M. Revenues reflects increased sales of Stellar products. Higher losses reflect increased interest expense resulting from loans payable to Company's Chairman and a $2.5M preferred dividend expense.